Involvement of capsular polysaccharide via a TLR2/NF-κB pathway in Vibrio vulnificus-induced IL-8 secretion of human intestinal epithelial cells

International Journal of Molecular Medicine

Volumn 25, Issue 4, 2010, Pages 581-591

  Lee, Byung Cheol ^a   Kim, Myun Soo ^a   Choi, Sang Ho ^b   Kim, Tae Sung ^a  

^a Korea University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Capsular polysaccharide; Interleukin 8; Intestinal epithelial cell; Nuclear factor B; Toll like receptor 2; Vibrio vulnificus

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN; BETA ACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PROTEIN WBPP; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL MEMBRANE; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIBRIO VULNIFICUS; WESTERN BLOTTING;

BACTERIAL CAPSULES; CARBOHYDRATE EPIMERASES; CELL LINE; ENTEROCYTES; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-8; MUTATION; NF-KAPPA B; POLYSACCHARIDES, BACTERIAL; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; VIBRIO VULNIFICUS;

EID: 77749273821     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm-00000380     Document Type: Article

References (40)

1. Jones MK and Oliver JD: Vibrio vulnificus: disease and pathogenesis. Infect Immun 77: 1723-1733, 2009.
2. Strom MS and Paranjpye RN: Epidemiology and pathogenesis of Vibrio vulnificus. Microb Infect 2: 177-188, 2000.
3. Amaro C, Fouz B, Biosca EG, Marco-Noales E and Collado R: The polysaccharide O side chain of Vibrio vulnificus sero-group E is a virulence determinant for eels. Infect Immun 65: 2475-2479, 1997.
4. Powell JL, Wright AC, Wasserman SS, Hone DM and Morris JG Jr: Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in vivo and in vitro models. Infect Immun 65: 3713-3718, 1997.
5. Wright AC, Powell JL, Kaper JB and Morris JG Jr: Identification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus. Infect Immun 69: 6893-6901, 2001.
6. Wright AC, Powell JL, Tanner MK, Ensor LA, Karpas AB, Morris G Jr and Sztein MB: Differential expression of Vibrio vulnificus capsular polysaccharide. Infect Immun 67: 2250-2257, 1999.
7. Simpson LM and Oliver JD: Siderophore production by Vibrio vulnificus. Infect Immun 41: 644-649, 1983.
8. Gray LD and Kreger AS: Purification and characterization of extracellular cytolysin produced by Vibrio vulnificus. Infect Immun 48: 67-72, 1985.
9. Jeong KC, Jeong HS, Rhee JH, Lee SE, Chung SS, Starks AM, Escudero GM, Gulig PA and Choi SH: Construction and phenotypic evaluation of a Vibrio vulnificus vvpE mutant for elastolytic protease. Infect Immun 68: 5096-5106, 2000.
10. Testa J, Daniel LW and Kreger AS: Extracellular phospholipase A2 and lysophospholipase produced by Vibrio vulnificus. Infect Immun 45: 458-463, 1984.
11. Lee JH, Kim MW, Kim BS, Kim SM, Lee BC, Kim TS and Choi SH: Identification and characterization of the Vibrio vulnificus rtxA essential for cytotoxicity in vitro and virulence in mice. J Microbiol 45: 146-152, 2007.
12. Lee JH, Rho JB, Park KJ, Kim CB, HanYS, Choi SH, Lee KH and Park SJ: Role of flagellum and motility in pathogenesis of Vibrio vulnificus. Infect Immun 72: 4905-4910, 2004.
13. Espat NJ, Auffenberg T, Abouhamze A, Baumhofer J, Moldawer LL, and Howard RJ: A role for tumor necrosis factor-α in the increased mortality associated with Vibrio vulnificus infection in the presence of hepatic dysfunction. Ann Surg 223: 428-433, 1996.
14. Lee BC, Kim SH, Choi SH and Kim TS: Induction of interleukin-8 production via nuclear factor-κB activation in human intestinal epithelial cells infected with Vibrio vulnificus. Immunology 115: 506-515, 2005.
15. Hsieh YC, Liang SM, Tsai WL, Chen YH, Liu TY and Liang CM: Study of capsular polysaccharide from Vibrio parahaemolyticus. Infect Immun 71: 3329-3336, 2003.
16. Hayat U, Reddy GP, Bush CA, Johnson JA, Wright AC and Morris JG Jr: Capsular types of Vibrio vulnificus: an analysis of strains from clinical and environmental sources. J Infect Dis 168: 758-762, 1993.
17. Bush CA, Patel P, Gunawardena S, Powell J, Joseph A, Johnson JA and Morris JG Jr: Classification of Vibrio vulnificus strains by the carbohydrate composition of their capsular polysaccharides. Anal Biochem 250: 186-195, 1997.
18. Reddy GP, Hayat U, Abeygunawaradena C, Fox C, Wright AC, Maneval DR Jr, Bush CA and Morris JG Jr: Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus M06-24. J Bacteriol 174: 2620-2630, 1992.
19. Smith A and Siebeling RJ: Identification of genetic loci required for capsular expression in Vibrio vulnificus. Infect Immun 71: 1091-1097, 2003.
20. Zuppardo AB and Siebeling RJ: An epimerase gene essential for capsule synthesis in Vibrio vulnificus. Infect Immun 66: 2601-2606, 1998.
21. Bleanger M, Burrows LL and Lam JS: Functional analysis of genes responsible for the synthesis of the B-band O antigen of Pseudomonas aeruginosa serotype O6 lipopolysaccharide. Microbiology 145: 3505-3521, 1999.
22. Park NY, Lee JH, Kim MW, Jeong HG, Lee BC, Kim TS and Choi SH: Identification of the Vibrio vulnificus wbpP gene and evaluation of its role in virulence. Infect Immun 74: 721-728, 2006.
23. Sharma SA, Tummuru MK, Blaser MJ and Kerr LD: Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol 160: 2401-2407, 1998.
24. Ishihara S, Rumi MA, Kadowaki Y, Ortega-Cava CF, Yuki T, Yoshino N, Miyaoka Y, Kazumori H, Ishimura N, Amino Y and Kinoshita Y: Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J Immunol 173: 1406-1416, 2004.
25. Yu Y, Zeng H, Lyons S, Carlson A, Merlin D, Neish AS and Gewirtz AT: TLR5-mediated activation of p38 MAPK regulates epithelial IL-8 expression via posttranscriptional mechanism. Am J Physiol Gastrointest Liver Physiol 285: G282-G290, 2003.
26. Abreu MT, Fukata M and Arditi M: TLR signaling in the gut in health and disease. J Immunol 174: 4453-4460, 2005.
27. Nishimura M and Naito S: Tissue-specific mRNA expression profiles of human Toll-like receptors and related genes. Biol Pharm Bull 28: 886-892, 2005.
28. Lee BC, Lee JH, Kim MW, Kim MC, Oh MW, Kim KS, Kim TS and Choi SH: Vibrio vulnificus rtxE is important for virulence, and its expression is induced by exposure to host cells. Infect Immun 76: 1509-1517, 2008.
29. Enos-Berlage JL and McCarter LL: Relation of capsular polysaccharide production and colonial cell organization to colony morphology in Vibrio parahaemolyticus. J Bacteriol 182: 5513-5520, 2000.
30. Jung YD, Fan F, McConkey DJ, Jean ME, Liu W, Reinmuth N, Stoeltzing O, Ahmad SA, Parikh AA, Mukaida N and Ellis LM: Role of p38 MAPK, AP-1, and NF-κB in interleukin-1β-induced IL-8 expression in human vascular smooth muscle cells Cytokine 18: 206-213, 2002.
31. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T and Akira S: Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin-6 and interleukin-8. Proc Natl Acad Sci USA 90: 10193-10197, 1993.
32. Haller D, Holt L, Parlesak A, Zanga J, Baueriein A and Jobin C: Differential effect of immune cells on non-pathogenic Gramnegative bacteria induced nuclear factor-κB activation and proinflammatory gene expression in intestinal epithelial cells. Immunology 112: 310-320, 2004.
33. Hosoi T, Hirose R, Saegusa S, Ametani A, Kiuchi K and Kaminogawa S: Cytokine responses of human intestinal epithelial-like Caco-2 cells to the nonpathogenic bacterium Bacillus subtilis (natto). Int J Food Microbiol 15: 255-264, 2003.
34. Goo SY, Han YS, Kim WH, Lee KH and Park SJ: Vibrio vulnificus IIpA-induced cytokine production is mediated by Toll-like receptor 2. J Biol Chem 282: 27647-27658, 2007.
35. Duenas AI, Orduna A, Crespo MS and Garcia-Rodriguez C: Interaction of endotoxins with Toll-like receptor 4 correlates with their endotoxic potential and may explain the proinflammatory effect of Brucella spp LPS. Int Immunol 16: 1467-1475, 2004.
36. Mitsuzawa H, Nishitani C, Hyakushima N, Shimizu T, Sano H, Matsushima N, Fukase K and Kuroki Y: Recombinant soluble forms of extracellular TLR4 domain and MD-2 inhibit lipopoly-saccharide binding on cell surface and dampen lipopolysaccharide-induced pulmonary inflammation in mice. J Immunol 177: 8133-8139, 2006.
37. Wullt B, Bergsten G, Connell H, Rollano P, Gebratsedik N, Hang L and Svanborg C: P-fimbriae trigger mucosal responses to Escherichia coli in the human urinary tract. Cell Microbiol 3: 255-264, 2001.
38. Urban TA, Griffith A, Torok AM, Smolkin ME, Burns JL and Goldberg JB: Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation. Infect Immun 72: 5126-5134, 2004.
39. Yu Y, Nagai S, Wu H, Neish AS, Koyasu S and Gewirtz AT: TLR5-mediated phosphoinositide 3-kinase activation negatively regulates flagellin-induced proinflammatory gene expression. J Immunol 176: 6194-6201, 2006.
40. Lee SE, Kim SY, Jeong BC, Kim YR, Bae SJ, Ahn OS, Lee JJ, Song HC, Kim JM, Choy HE, Chung SS, Kweon MN and Rhee JH: A bacterial Flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity. Infect Immun 74: 694-702, 2006.